Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases-Reference-Cited by-同舟云学术

Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases

Published:2011-12-05 Issue:D1 Volume:40 Page:D992-D1002
ISSN:1362-4962
Container-title:Nucleic Acids Research
language:en
Short-container-title:

Author:

Caputo Sandrine¹,Benboudjema Louisa¹,Sinilnikova Olga¹¹,Rouleau Etienne¹,Béroud Christophe¹¹¹,Lidereau Rosette¹,

Affiliation:

1. Institut Curie—Hôpital René Huguenin, Service d'Oncogénétique, U735 INSERM—Saint-Cloud, 2Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon—Centre Léon Bérard, Lyon, 3INSERM U1052, CNRS UMR5286, Université Lyon 1, Centrede Recherche en Cancérologie de Lyon, Lyon, 4INSERM U827—Montpellier, 5CHU Montpellier, Hôpital Arnaud de Villeneuve, Laboratoire de Génétique Moléculaire—Montpellier and 6Université Montpellier1, UFR Médecine—Montpellier, F-34000, France

Publisher

Oxford University Press (OUP)

Subject

Genetics

Link

http://academic.oup.com/nar/article-pdf/40/D1/D992/16955239/gkr1160.pdf

Reference61 articles.

1. Genomic rearrangements in the BRCA1 and BRCA2 genes;Mazoyer;Hum. Mutat.,2005

2. Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation;Sluiter;Breast Cancer Res. Treat,2010

3. Does nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene?;Ware;Oncogene,2006

4. Does the nonsense-mediated mRNA decay mechanism prevent the synthesis of truncated BRCA1, CHK2, and p53 proteins?;Anczukow;Hum. Mutat.,2008

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased prevalence of the founder BRCA1 c.5309G>T and recurrent BRCA2 c.1310_1313delAAGA mutations in breast cancer families from Northerstern region of Morocco: evidence of geographical specificity and high relevance for genetic counseling;BMC Cancer;2023-04-13

2. A comprehensive survey on spectrum of BRCA1 and BRCA2 pathogenic variants in breast and ovarian cancer;Immunological Implications and Molecular Diagnostics of Genitourinary Cancer;2023

3. Inhibitors targeting epigenetic modifications in cancer;Transcription and Translation in Health and Disease;2023

4. Case Report: Male Lobular Breast Cancer in Hereditary Cancer Syndromes;Frontiers in Oncology;2022-05-24

5. Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa;BMC Cancer;2022-02-25